the rationale is due to the favorable responses observed in patients with metastatic bladder cancer , the high systemic relapse rate after apparent local control with either surgery or radiotherapy , the potential for using the bladder lesion as a indicator for selecting patients responsive to chemotherapy , and the ultimate possibility of bladder preservation .
C0278828
metastatic bladder cancer
C0005682
bladder